AVNS

Avanos Medical, Inc. NYSE

Healthcare ·Medical - Devices ·US · avanos.com

$24.67

Mkt Cap $1.2B

52w Low $9.30 99.5% of range 52w High $24.75

50d MA $16.87 200d MA $13.14

P/E (TTM) -16.9x

EV/EBITDA -16.9x

P/B 1.5x

Debt/Equity 0.2x

ROE -9.4%

P/FCF 12.1x

RSI (14) —

ATR (14) —

Beta 1.05

50d MA $16.87

200d MA $13.14

Avg Volume 1.2M

About

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 24, 2026	AMC	0.24	0.29	+20.8%	13.64	+0.1%	+5.3%	+6.2%	+3.4%	+2.5%	+2.6%	+1.5%	—
Nov 5, 2025	AMC	0.12	0.22	+83.3%	10.66	+0.7%	+4.9%	+5.3%	+7.3%	+9.4%	+10.3%	+5.6%	—
Aug 5, 2025	AMC	0.18	0.17	-5.6%	9.89	+0.1%	+4.4%	+8.6%	+9.4%	+6.4%	+9.1%	+28.0%	—
May 6, 2025	AMC	0.19	0.26	+36.8%	12.85	-0.1%	-2.1%	-2.1%	-1.6%	+1.9%	-1.1%	-4.0%	—
Feb 26, 2025	AMC	0.40	0.43	+7.5%	15.62	-1.7%	-2.6%	-3.6%	-3.1%	-3.8%	-2.0%	-10.7%	—
Oct 30, 2024	AMC	0.36	0.36	+0.0%	18.58	+1.0%	+0.5%	+0.7%	+3.4%	+6.5%	+12.8%	+3.1%	—
Jul 31, 2024	AMC	0.29	0.34	+17.2%	23.92	-0.2%	-0.7%	+0.4%	-4.1%	-4.1%	-6.0%	+1.3%	—
May 2, 2024	AMC	0.21	0.22	+4.8%	19.71	+1.2%	-0.2%	+0.1%	-0.9%	-0.8%	-1.2%	+3.2%	—
Feb 20, 2024	AMC	0.37	0.36	-2.7%	19.50	+0.4%	+0.1%	+0.5%	+1.0%	-1.2%	-0.8%	-0.1%	—
Nov 1, 2023	AMC	0.29	0.30	+3.4%	20.79	-0.6%	+3.5%	+6.3%	+4.5%	+2.0%	+1.4%	+6.3%	—
Aug 9, 2023	AMC	0.34	0.24	-29.4%	23.41	-0.2%	-0.6%	-3.6%	-4.4%	-5.0%	-6.2%	-14.1%	—
May 3, 2023	AMC	0.28	0.27	-3.6%	24.44	-3.7%	-3.7%	-1.9%	-4.1%	-5.8%	-4.6%	+1.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jul 25	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$25.54	$24.29	-4.9%	-4.3%	-3.0%	-4.7%	-4.5%	-4.2%
Jun 21	Stifel	Maintains	Hold → Hold	—	$25.59	$25.50	-0.4%	+0.1%	+2.0%	+1.1%	-0.3%	-0.0%
May 4	Morgan Stanley	Maintains	Underweight → Underweight	—	$24.44	$23.53	-3.7%	-3.7%	-1.9%	-4.1%	-5.8%	-4.6%
Feb 22	Morgan Stanley	Maintains	Underweight → Underweight	—	$29.01	$29.03	+0.1%	+0.4%	+1.0%	-1.2%	-2.6%	-3.2%
Jan 6	Morgan Stanley	Maintains	Underweight → Underweight	—	$26.92	$27.23	+1.2%	+0.5%	+0.3%	+1.9%	+3.6%	+7.4%
Nov 3	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$23.17	$22.73	-1.9%	-3.3%	-1.8%	+3.8%	+3.3%	+4.5%
Oct 11	Morgan Stanley	Maintains	Underweight → Underweight	—	$20.94	$20.62	-1.5%	-1.1%	-5.1%	-3.2%	-4.6%	+0.5%
Aug 10	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$28.84	$28.80	-0.1%	-2.2%	-1.8%	+0.9%	+2.6%	-1.6%
Jul 18	Stifel	Maintains	Hold → Hold	—	$26.85	$26.84	-0.0%	-1.5%	+2.1%	+2.3%	+4.1%	+3.5%
Jul 15	Morgan Stanley	Maintains	Underweight → Underweight	—	$26.30	$26.84	+2.1%	+2.1%	+0.6%	+4.2%	+4.4%	+6.3%
May 5	Morgan Stanley	Maintains	Underweight → Underweight	—	$30.73	$29.84	-2.9%	-4.2%	-9.7%	-16.4%	-17.5%	-18.4%
Feb 24	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$31.69	$31.48	-0.7%	+7.2%	+11.7%	+11.7%	+10.2%	+9.2%
Jan 7	Morgan Stanley	Maintains	Underweight → Underweight	—	$34.52	$33.73	-2.3%	-3.5%	-0.9%	-5.2%	-6.7%	-5.4%
Aug 4	Stephens & Co.	Downgrade	Overweight → Equal Weight	—	$36.93	$35.05	-5.1%	-8.0%	-7.8%	-6.0%	-8.0%	-9.2%
Aug 4	Morgan Stanley	Maintains	Underweight → Underweight	—	$36.93	$35.05	-5.1%	-8.0%	-7.8%	-6.0%	-8.0%	-9.2%
Aug 4	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$36.93	$35.05	-5.1%	-8.0%	-7.8%	-6.0%	-8.0%	-9.2%
Jan 8	KeyBanc	Maintains	Overweight → Overweight	—	$48.58	$49.22	+1.3%	-1.1%	-1.3%	-0.8%	-1.0%	-0.2%
Dec 15	Morgan Stanley	Maintains	Underweight → Underweight	—	$47.27	$48.07	+1.7%	+1.2%	+1.7%	+4.7%	+1.5%	-1.5%
Nov 4	Morgan Stanley	Maintains	Underweight → Underweight	—	$40.32	$40.13	-0.5%	+0.5%	-1.1%	-1.4%	+2.9%	+5.8%
Nov 4	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$40.32	$40.13	-0.5%	+0.5%	-1.1%	-1.4%	+2.9%	+5.8%
Nov 4	KeyBanc	Maintains	Overweight → Overweight	—	$40.32	$40.13	-0.5%	+0.5%	-1.1%	-1.4%	+2.9%	+5.8%
Aug 5	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$32.50	$32.62	+0.4%	-4.9%	-5.0%	-4.2%	-4.1%	-2.3%
Aug 5	KeyBanc	Maintains	Overweight → Overweight	—	$32.50	$32.62	+0.4%	-4.9%	-5.0%	-4.2%	-4.1%	-2.3%
May 7	Morgan Stanley	Maintains	Underweight → Underweight	—	$30.36	$31.15	+2.6%	-4.9%	-7.5%	-7.0%	-11.2%	-15.1%
Apr 27	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$29.99	$30.32	+1.1%	+4.9%	+2.1%	+7.1%	+3.5%	+3.6%
Apr 27	KeyBanc	Maintains	Overweight → Overweight	—	$29.99	$30.32	+1.1%	+4.9%	+2.1%	+7.1%	+3.5%	+3.6%
Apr 13	Barclays	Upgrade	Underweight → Equal Weight	—	$28.95	$29.06	+0.4%	-2.0%	+6.9%	-0.8%	+1.8%	+6.7%
Apr 1	Stifel	Maintains	Hold → Hold	—	$26.93	$25.49	-5.3%	-12.8%	-8.6%	-11.8%	-4.4%	-3.6%
Mar 27	Morgan Stanley	Maintains	Underweight → Underweight	—	$25.58	$24.49	-4.3%	-2.0%	+5.6%	+5.3%	-8.2%	-3.8%
Mar 23	Stephens & Co.	Maintains	Overweight → Overweight	—	$21.14	$21.39	+1.2%	-2.4%	+9.8%	+8.5%	+21.0%	+18.5%
Dec 17	Morgan Stanley	Maintains	Underweight → Underweight	—	$33.24	$32.84	-1.2%	-3.6%	-1.7%	-1.3%	-1.9%	+1.4%
Nov 7	Stifel Nicolaus	Downgrade	Buy → Hold	—	$34.27	$34.00	-0.8%	-1.0%	+3.7%	+0.1%	-1.4%	-4.9%
Nov 7	Stifel	Downgrade	Buy → Hold	—	$34.27	$34.00	-0.8%	-1.0%	+3.7%	+0.1%	-1.4%	-4.9%
Nov 6	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$37.08	$35.85	-3.3%	-7.6%	-8.5%	-4.2%	-7.5%	-8.9%
Nov 6	Raymond James	Downgrade	Outperform → Market Perform	—	$37.08	$35.85	-3.3%	-7.6%	-8.5%	-4.2%	-7.5%	-8.9%
Nov 6	KeyBanc	Maintains	Overweight → Overweight	—	$37.08	$35.85	-3.3%	-7.6%	-8.5%	-4.2%	-7.5%	-8.9%
Aug 7	Raymond James	Maintains	Outperform → Outperform	—	$37.23	$37.00	-0.6%	-1.7%	+4.0%	+2.5%	+0.5%	-0.6%
Feb 27	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$50.50	$50.15	-0.7%	-5.7%	-6.8%	-5.2%	-4.1%	-7.1%
Feb 27	KeyBanc	Maintains	Overweight → Overweight	—	$50.50	$50.15	-0.7%	-5.7%	-6.8%	-5.2%	-4.1%	-7.1%
Jan 4	Barclays	Downgrade	Equal Weight → Underweight	—	$41.49	$38.15	-8.1%	-4.0%	+1.3%	+3.7%	+7.5%	+8.2%
Dec 18	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$47.59	$47.60	+0.0%	-0.4%	-6.1%	-7.5%	-9.6%	-13.5%
Dec 18	KeyBanc	Maintains	Overweight → Overweight	—	$47.59	$47.60	+0.0%	-0.4%	-6.1%	-7.5%	-9.6%	-13.5%
Oct 11	Morgan Stanley	Maintains	Underweight → Underweight	—	$61.48	$61.10	-0.6%	-3.3%	-3.3%	-2.4%	+0.3%	+0.9%
Aug 21	Raymond James	Upgrade	Market Perform → Outperform	—	$66.05	$69.60	+5.4%	+5.5%	+8.4%	+9.0%	+9.4%	+9.2%
Aug 8	Morgan Stanley	Maintains	Underweight → Underweight	—	$65.75	$65.50	-0.4%	-3.0%	-4.0%	-4.6%	-4.8%	-3.8%
Aug 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$65.75	$65.50	-0.4%	-3.0%	-4.0%	-4.6%	-4.8%	-3.8%
Aug 8	KeyBanc	Maintains	Overweight → Overweight	—	$65.75	$65.50	-0.4%	-3.0%	-4.0%	-4.6%	-4.8%	-3.8%

Recent Filings

8-K · 1.01 !!! Very High

Unknown — 8-K 1.01: Merger Agreement

AVNS shareholders will likely face significant dilution or a below-market acquisition price, as private equity takeovers typically involve substantial management fees and leverage that prioritize buyer returns over public shareholders.

Apr 14

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

The departure of a key executive at Avans could disrupt operational continuity and investor confidence, particularly if no qualified successor is immediately named, potentially pressuring the stock near-term.

Mar 12

8-K · 8.01 !! High

Avanos Medical, Inc. -- 8-K 8.01: Material Event / Announcement

Avanos Medical announced it will nominate Mr. Cunniff to its Board of Directors at the 2026 Annual Meeting, signaling potential strategic leadership changes.

Feb 26

8-K

Avanos Medical, Inc. -- 8-K Filing

This appears to be a routine investor relations contact update for Avanos Medical rather than a material corporate event requiring investor analysis.

Feb 24

Data updated apr 24, 2026 7:59pm · Source: massive.com